CLEER THE AIR

Discussing the science behind Cleerly's new standard of care for heart disease.

3 min read

Q&A with Dr. James Earls: New Clinical Research Shared at ACC.23/WCC

Cleerly attended the American College of Cardiology conference (ACC.23/WCC) to showcase our efforts in providing a safe and effective approach to understanding cardiovascular disease risk and guiding personalized treatment. Our team presented...

Read More »

3 min read

How Precision Heart Care Impacts the Patient and Provider Experience

According to the American Heart Association (AHA), nearly half of Americans have some type of cardiovascular disease.1 Despite such wide prevalence, we struggle to provide these patients with the care they need. When patients present to their physicians...

Read More »

4 min read

Atherosclerosis Treatment Algorithms for Heart Disease Evaluation

Quantification of coronary artery disease (CAD) burden and atherosclerotic plaque type has been shown to be the strongest determinant of future risk of major adverse cardiac events (MACE).1 Until recently, though, there had been no clinically useful...

Read More »

3 min read

How AI-enabled CCTA Creates Value by Reducing Downstream Costs

Care quality is a pillar of the Quadruple Aim for a reason. Stakeholders across the healthcare ecosystem benefit when patients have access to the right services at the right time. This improves outcomes while reducing the utilization of low-quality – and...

Read More »

4 min read

Understanding Your Heart Disease Risk

Heart disease is the cause of death for 700,000 Americans1 and nearly 17.9 million people worldwide every year.2 While some of these individuals likely had indicators for higher risk, such as high cholesterol or high blood pressure, studies show that up...

Read More »

4 min read

Cleerly Value to Health Systems: Precision Heart Care Reduces Risk and Improves Patient Care

Current methodologies for coronary artery disease (CAD) screening often result in misidentification of low-risk patients and may submit patients to unnecessary and expensive invasive procedures.

Cleerly’s coronary computed tomography angiography...

Read More »

2 min read

Cleerly Value to Health Plans: Precision Heart Care Reduces Waste and Improves Patient Experience

Cleerly is making the future of cardiovascular care possible through easy-to-use, clinically proven technology that effortlessly integrates into provider workflows and patient care journeys.

Our personalized care pathway for heart attack prevention...

Read More »

3 min read

Cleerly Value to Private Practice: Precision Heart Care Allows for Personalized Heart Disease Evaluation

Current methodologies for screening for coronary artery disease (CAD) at the primary care provider’s office are often limited. And once heart disease is suspected or identified by these methods, patients must often be referred to a specialist for...

Read More »

2 min read

What to Expect with a CCTA Scan

Cleerly makes early detection of heart disease risk possible through our AI-enabled analysis of coronary computed tomography angiography (CCTA) imaging that guides physicians towards creating personalized and preventive treatment plans for patients. To...

Read More »

3 min read

Better Defining Heart Disease Risk Through Proper Evaluation

Cleerly’s Medical Affairs team had the opportunity to present at the American Heart Association’s (AHA) 2022 Scientific Sessions this past week in Chicago. This event brings together the brightest scientific and clinical minds in cardiovascular and brain...

Read More »